EBC - ON DEMAND
European Bifurcation Club 2015 – EBC 2015 – Athens, Greece
Dedicated bifurcation stents 1
Update from the Tryton IDE study
Author: Maciej Lesiak
CONCLUSION TRYTON TRIAL
- The Tryton two-stent strategy in true bifurcations (88%) compared with the provisional strategy (8.0% side branch stents) did not meet the non-inferiority clinical endpoint (TVF), due to a relatively higher frequency of small peri-procedural CK-MB elevations.
- However, both strategies were safe (rare clinically significant MIs and stent thrombosis) and both had low 9-month clinically-driven TVR (P:3.6%,T:4.7%).
- Tryton improved side branch % diameter stenosis at FU (secondary endpoint; P=0.002)